What is the most appropriate antidepressant to switch to for a patient experiencing severe constipation while taking sertraline?

Switching from Sertraline Due to Severe Constipation

For a patient experiencing severe constipation on sertraline, switch to bupropion or mirtazapine as the preferred alternatives, with bupropion being the first choice for most patients unless sedation and appetite stimulation are desired. 1

Rationale for Switching

Sertraline, like other SSRIs, commonly causes gastrointestinal side effects including constipation, though diarrhea is actually more typical. 2 However, when constipation does occur with SSRIs, it can be severe enough to warrant medication change. 3

Primary Recommendation: Bupropion

Bupropion is the optimal first-line alternative for patients with SSRI-induced constipation. 1

• The American College of Physicians specifically recommends bupropion over SNRIs (like duloxetine or venlafaxine) for patients at risk of constipation. 1
• Bupropion has a unique mechanism as the only antidepressant affecting norepinephrine and dopamine without serotonergic activity, which reduces gastrointestinal side effects. 4
• Common side effects include agitation, dry mouth, insomnia, and headache—but notably not constipation in most cases. 4
• Onset of action is 2 weeks with full efficacy at 4 weeks, producing similar remission rates to SSRIs. 4

Important Caveat About Bupropion

One case report documented severe constipation with extended-release bupropion requiring hemorrhoidectomy, though this appears rare. 5 This paradoxical effect should be monitored, but the overall evidence and guideline recommendations still favor bupropion for constipation-prone patients. 1

Dosing Considerations for Bupropion

• Maximum dose: 450 mg/day for immediate-release or 400 mg/day for sustained-release formulations. 4
• Gradual titration is essential due to seizure risk at higher doses. 4

Alternative Recommendation: Mirtazapine

Mirtazapine is the second-best option, particularly for patients who would benefit from sedation and appetite stimulation. 2

• Mirtazapine showed the fewest gastrointestinal side effects among all antidepressants studied, being associated only with increased appetite—not constipation, nausea, or diarrhea. 2
• It enhances norepinephrine and serotonin through alpha-2 receptor blockade rather than reuptake inhibition. 4
• Significant improvement occurs within 1-2 weeks, faster than most antidepressants. 4
• Dose range: 15-45 mg once daily at bedtime. 4

Side Effect Profile of Mirtazapine

• Primary side effects are sedation (often beneficial for insomnia), increased appetite, and weight gain. 4
• These effects may be desirable in patients with depression-related insomnia or poor appetite. 4

Options to Avoid

Do NOT switch to SNRIs (duloxetine, venlafaxine, desvenlafaxine) in patients with constipation concerns:

• SNRIs can cause or worsen constipation and should be avoided in patients already experiencing this problem. 1
• The American Gastroenterological Association specifically notes SNRIs worsen constipation in gastroparesis. 1
• For patients with IBS-C, secondary amine TCAs are better tolerated than SNRIs due to lower anticholinergic effects. 1

Tricyclic antidepressants should generally be avoided despite their efficacy in IBS and pain syndromes, as their anticholinergic properties frequently cause constipation. 3

Clinical Algorithm

1. First choice: Switch to bupropion (start 150 mg daily, titrate as needed)
2. If sedation/appetite stimulation needed: Choose mirtazapine instead (start 15 mg at bedtime)
3. Monitor: Assess bowel function within 1-2 weeks of switching
4. Avoid: SNRIs and TCAs in constipation-prone patients

Managing the Transition

• Direct switch is generally safe between these medications, though gradual cross-titration may reduce withdrawal symptoms from sertraline. 3
• Sertraline's 26-hour half-life allows for relatively smooth transitions. 6
• Counsel patients that antidepressant efficacy should be evident within 2-4 weeks of the new medication. 4